Index by author
June 01, 2004; Volume 32,Issue 6
A
Anderton, Mark J.
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
Anzenbacher, Pavel
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
Arimori, Kazuhiko
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
B
Baillie, Thomas A.
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
Black, Virginia H.
- You have accessMOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLSVirginia H. Black and Linda C. QuattrochiDrug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595
Borlak, Jürgen
- You have accessANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATSJürgen Borlak, Ingo Schulte and Thomas ThumDrug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
Bridges, Alexander J.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Buist, Susan C. N.
- You have accessRAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELSSusan C. N. Buist and Curtis D. KlaassenDrug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620
C
Cai, Xiaoxin
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
D
Dean, Dennis C.
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
E
Edom, Richard W.
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
Evans, David C.
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
F
Frandsen, H.
- You have accessIDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)H. Frederiksen and H. FrandsenDrug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661
Frederiksen, H.
- You have accessIDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)H. Frederiksen and H. FrandsenDrug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661
Fujita, Ken-ichi
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
G
Gescher, Andreas
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
Goosen, Theunis C.
- You have accessSILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESChitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. HollenbergDrug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
Guengerich, F. Peter
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
Gut, Ivan
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
H
He, Kan
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Hidaka, Muneaki
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
Hollenberg, Paul F.
- You have accessSILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESChitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. HollenbergDrug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
I
Iwakiri, Tomomi
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
J
Juntunen, Tarja
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
K
Kent, Ute M.
- You have accessSILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESChitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. HollenbergDrug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
Klaassen, Curtis D.
- You have accessRAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELSSusan C. N. Buist and Curtis D. KlaassenDrug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620
Kodama, Hirofumi
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
L
Liu, Wensheng
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
M
Mager, Donald E.
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
Manson, Margaret M.
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
N
Nieminen, Riina
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
O
Obach, R. Scott
- You have accessVALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIESRobert L. Walsky and R. Scott ObachDrug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647
Ogikubo, Tetsuya
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
Okumura, Manabu
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
P
Pelkonen, Olavi
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
Pool, William F.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Q
Quattrochi, Linda C.
- You have accessMOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLSVirginia H. Black and Linda C. QuattrochiDrug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595
R
Raunio, Hannu
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
Reed, Jessica E.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Reily, Michael D.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Rodrigues, A. David
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
S
Schulte, Ingo
- You have accessANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATSJürgen Borlak, Ingo Schulte and Thomas ThumDrug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
Shou, Magang
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
Simek, Petr
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
Smith, Brian R.
- You have accessA COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCEKeith W. Ward and Brian R. SmithDrug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
- You have accessA COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIMEKeith W. Ward and Brian R. SmithDrug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612
Soucek, Pavel
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
Sridar, Chitra
- You have accessSILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESChitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. HollenbergDrug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
Steward, William P.
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
Svobodova, Lenka
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
T
Taavitsainen, Päivi
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
Talaat, Rasmy E.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Thum, Thomas
- You have accessANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATSJürgen Borlak, Ingo Schulte and Thomas ThumDrug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
Turpeinen, Miia
- You have accessSELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITROMiia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi PelkonenDrug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
V
Vaclavikova, Radka
- You have accessDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGSRadka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan GutDrug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
Verschoyle, Richard
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
W
Walsky, Robert L.
- You have accessVALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIESRobert L. Walsky and R. Scott ObachDrug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647
Wang, Regina W.
- You have accessVALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMESXiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. BaillieDrug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
Ward, Keith W.
- You have accessA COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCEKeith W. Ward and Brian R. SmithDrug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
- You have accessA COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIMEKeith W. Ward and Brian R. SmithDrug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612
Williams, J. Andrew
- You have accessSILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESChitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. HollenbergDrug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
Williams, Marion L.
- You have accessPHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICEMark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. MagerDrug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
Woolf, Thomas F.
- You have accessMETABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVEDKan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. WoolfDrug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
Y
Yamasaki, Keishi
- You have accessPOTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITYMuneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko ArimoriDrug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581